We provide you with 20 years of free, institutional-grade data for DYAI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of DYAI. Explore the full financial landscape of DYAI stock.
| Reported Date | CIK | Ticker | Type |
|---|
Dyadic International, Inc(NASDAQ:DYAI) 
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 technology and other technologies to conduct research, development, and commercial activities for the deve...
Website: http://www.dyadic.com
Founded: 1979
Full Time Employees: 6
CEO: Mark A. Emalfarb
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about DYAI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.